戻る Agenda
Perspectives on Medication Errors
Session Chair(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
Medication errors cause a large number of adverse drug reactions (ADRs) with negative patient health outcomes each year. The new pharmacovigilance legislation expanded the obligations related to medication error which presents some interesting challenges. This session will look at: • Real experiences from the perspective of a regulatory authority • Practical challenges for the industry related to coding of medication errors • Perspectives of patients and healthcare professionals
Speaker(s)
Medication Errors Provide a Challenge for Pharmacovigilance – Experiences of a Regulatory Authority
Claudia Kayser
BfArM, Germany
Regulatory Affairs Manager, Pharmaceutical-Pharmacological Assessor
How Do MedDRA Terminology Changes Affect Our Data / Our Interpretation of Verbatims Associated with Off-Label Use
Maren Enssle, RN
Abbott Laboratories, Germany
Meddra Specialist
Medication Errors – The Perspective of Patients and Healthcare Professionals Relating to Identification of Issues and Collection of Data
Kristina Strutt, MD, MA, MRCP, FFPM
Ipsen Biopharm Limited, United Kingdom
Senior Vice President